These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20385448)

  • 1. Let''s try erythropoietin in Alzheimer's disease.
    Modabbernia A; Ashrafi M; Modabbernia MJ
    Med Hypotheses; 2010 Aug; 75(2):270-1. PubMed ID: 20385448
    [No Abstract]   [Full Text] [Related]  

  • 2. [New therapeutic strategies in Alzheimer's disease].
    Salamaca-Gómez F
    Gac Med Mex; 2002; 138(5):493-4. PubMed ID: 12404733
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.
    Roher AE; Kokjohn TA
    Alzheimers Dement; 2009 Sep; 5(5):437-8. PubMed ID: 19751925
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment for Alzheimer's disease?
    Growdon JH
    N Engl J Med; 1992 Oct; 327(18):1306-8. PubMed ID: 1357552
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxidative damage and Alzheimer's disease: are antioxidant therapies useful?
    Moreira PI; Smith MA; Zhu X; Honda K; Lee HG; Aliev G; Perry G
    Drug News Perspect; 2005; 18(1):13-9. PubMed ID: 15753972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
    Relkin NR
    Expert Rev Neurother; 2007 Jun; 7(6):735-48. PubMed ID: 17561789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach.
    Davidson M; Stern RG
    Psychiatr Clin North Am; 1991 Jun; 14(2):461-82. PubMed ID: 2062728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drug available for Alzheimer's disease.
    Bailey C
    Colo Nurse; 1997 Mar; 97(1):12. PubMed ID: 9095790
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic approaches for Alzheimer's disease.
    Jahnke U
    IDrugs; 2008 Jan; 11(1):4-6. PubMed ID: 18175250
    [No Abstract]   [Full Text] [Related]  

  • 10. Neural stem cells, acetylcholine and Alzheimer's disease.
    Fullwood NJ
    Nat Chem Biol; 2007 Aug; 3(8):435. PubMed ID: 17637767
    [No Abstract]   [Full Text] [Related]  

  • 11. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets.
    Caraci F; Copani A; Nicoletti F; Drago F
    Eur J Pharmacol; 2010 Jan; 626(1):64-71. PubMed ID: 19837057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alzheimer's disease and cellular membranes].
    Coria Balanzat F
    Neurologia; 1998 Oct; 13(8):395-9. PubMed ID: 9859672
    [No Abstract]   [Full Text] [Related]  

  • 13. The medicinal chemistry of Alzheimer's and Alzheimer-like diseases with emphasis on the cholinergic hypothesis.
    Gualtieri F; Dei S; Manetti D; Romanelli MN; Scapecchi S; Teodori E
    Farmaco; 1995; 50(7-8):489-503. PubMed ID: 7669187
    [No Abstract]   [Full Text] [Related]  

  • 14. AF102B: rational treatment strategy for Alzheimer's disease: recent advances.
    Fisher A; Brandeis R; Karton I; Pittel Z; Dachir S; Sapir M; Grunfeld Y; Levy A; Heldman E
    Adv Neurol; 1990; 51():257-9. PubMed ID: 2403717
    [No Abstract]   [Full Text] [Related]  

  • 15. Carnosine, diabetes and Alzheimer's disease.
    Hipkiss AR
    Expert Rev Neurother; 2009 May; 9(5):583-5. PubMed ID: 19402768
    [No Abstract]   [Full Text] [Related]  

  • 16. Strategies for disease modification in Alzheimer's disease.
    Citron M
    Nat Rev Neurosci; 2004 Sep; 5(9):677-85. PubMed ID: 15322526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgens and Alzheimer's disease.
    Drummond ES; Harvey AR; Martins RN
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):254-9. PubMed ID: 19373081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen or testosterone may be effective agents in the management of both multiple myeloma and Alzheimer's disease.
    Ozen M; Karaahmet F; Tezcan ME; Bulut N; Altundag K
    Med Hypotheses; 2007; 68(1):231-2. PubMed ID: 16962721
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neuropeptides and Alzheimer's disease].
    Jiménez A; Astarloa R; Morales B
    Neurologia; 1991 Jan; 6(1):17-24. PubMed ID: 1677810
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholinergic and glutamatergic drugs in Alzheimer's disease therapy.
    Clarke NA; Francis PT
    Expert Rev Neurother; 2005 Sep; 5(5):671-82. PubMed ID: 16162091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.